How Hedge Funds Won Big on an Obscure Drugmaker
How Hedge Funds Won Big on an Obscure Drugmaker
Results of a Paris company’s late-stage drug trial helped turn things around for healthcare-focused funds, which struggled in the first half of the year.
Like
Dislike
Love
Angry
Sad
Funny
Wow
EU-China trade relations are in a 'slow-motion train accident,' business group says
April 22, 2024'Glitch' at Ethiopia's biggest bank sees customers withdraw millions that isn't theirs
April 22, 2024This is the easiest way for newbies to start investing, financial experts say
April 22, 2024
Comments 0